ACADIAN ASSET MANAGEMENT LLC - PROTEOSTASIS THERAPEUTICS IN ownership

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 47 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q1 2020. The put-call ratio across all filers is 2.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q3 2020$332,000
-31.3%
301,633
-14.6%
0.00%
-50.0%
Q2 2020$483,000
+16.9%
353,023
-2.7%
0.00%0.0%
Q1 2020$413,000
-32.2%
362,650
+35.8%
0.00%
-33.3%
Q4 2019$609,000
+150.6%
267,128
-7.4%
0.00%
+200.0%
Q3 2019$243,000
-33.4%
288,336
-22.8%
0.00%
-50.0%
Q2 2019$365,000
+25.9%
373,324
+61.7%
0.00%
+100.0%
Q1 2019$290,000
+133.9%
230,878
+350.3%
0.00%0.0%
Q3 2018$124,000
-12.1%
51,269
+1.3%
0.00%0.0%
Q2 2018$141,00050,6070.00%
Other shareholders
PROTEOSTASIS THERAPEUTICS IN shareholders Q1 2020
NameSharesValueWeighting ↓
VHCP Management III, LLC 848,610$2,749,0002.00%
GREAT POINT PARTNERS LLC 3,045,423$9,867,0001.25%
NEA Management Company, LLC 5,556,778$18,004,0000.71%
VHCP Management II, LLC 501,390$1,625,0000.70%
SECTORAL ASSET MANAGEMENT INC 1,581,728$5,125,0000.70%
HARBOURVEST PARTNERS LLC 440,627$1,428,0000.68%
EAM Investors, LLC 596,871$1,934,0000.52%
EAM Global Investors LLC 252,778$819,0000.45%
Avoro Capital Advisors LLC 1,300,000$4,212,0000.25%
Ghost Tree Capital, LLC 190,000$616,0000.22%
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders